Twist Bioscience Reports Record Revenue in 2024 - Markets Insider

4 days ago · In its fiscal year 2024, Twist Bioscience reported a record revenue of $313.0 million, marking a 28% increase from the previous year. The company also achieved a gross margin …

CouponFollow Extension

28%
OFF

Twist Bioscience Reports Record Revenue In 2024 - Markets Insider

6 days from now

4 days ago · In its fiscal year 2024, Twist Bioscience reported a record revenue of $313.0 million, marking a 28% increase from the previous year. The company also achieved a gross margin …

businessinsider.com

28%
OFF

SOUTH SAN FRANCISCO, Calif. -- — Twist Bioscience …

6 days from now

Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2024 Financial Results — Record revenue of $313.0 million in Fiscal 2024; Increase of 28% over $245.1 million in Fiscal …

twistbioscience.com

23%
OFF

Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: …

6 days from now

4 days ago · NGS Revenue: $45.5 million for Q4, a 23% increase year-over-year; $169.1 million for fiscal 2024, a 37% increase over fiscal 2023. Biopharma Revenue: $5.3 million for Q4; …

yahoo.com

$313
OFF

Twist Bioscience’s Strong Growth And Profitability ... - Markets …

6 days from now

5 days ago · The company’s fiscal year 2024 revenues of $313 million exceeded expectations, driven by strong performance in Next-Generation Sequencing (NGS) and the adoption of …

businessinsider.com

$81
OFF

Document - SEC.gov

6 days from now

Aug 2, 2024 · – Record revenue of $81.5M in 3QFY24, ... — Increased FY 2024 revenue guidance to approximately $310M to $311M; FY 2024 gross margin guidance at high end of …

sec.gov

5%
OFF

Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results

6 days from now

"We're starting fiscal 2024 off strong with record revenue of $71.5 million for the first fiscal quarter, coming in above our projection, with a gross margin of 40.5%," said Emily M. Leproust, Ph.D., …

twistbioscience.com

25%
OFF

Twist Bioscience Reports Fiscal Second Quarter 2024 Financial …

6 days from now

May 2, 2024 · – Record revenue of $75.3M in 2QFY24, an increase of 25% over $60.2M in 2QFY23 – ... — Increased FY 2024 revenue guidance to a range of $300M to $304M; …

businesswire.com

27%
OFF

Earnings Call: Twist Bioscience Reports Robust Q4 With Revenue Up …

6 days from now

4 days ago · Twist Bioscience Corporation (NASDAQ: NASDAQ: TWST) announced a strong finish to fiscal 2024, with Q4 revenue climbing to $84.7 million, a 27% increase compared to …

investing.com

$367
OFF

Twist Bioscience Sees FY25 Revenue $367M-$377M, Consensus …

6 days from now

5 days ago · Twist Bioscience reports Q4 EPS (59c), consensus (69c) Twist Bioscience sees Q1 revenue $87M, consensus $84.27M; Options Volatility and Implied Earnings Moves Today, …

nasdaq.com

2%
OFF

New Jersey MarketBeats | US | Cushman & Wakefield

6 days from now

Oct 8, 2024 · Northern New Jersey's office vacancy rate climbed to 23.2% by the end of the third quarter of 2024, up 160 basis points year-over-year. ... MarketBeat reports analyze quarterly …

cushmanwakefield.com

$87
OFF

Twist Bioscience Sees Q1 Revenue $87M, Consensus $84.27M

6 days from now

businessinsider.com

$1.01
OFF

IGM Biosciences (NASDAQ:IGMS) Shares Gap Down - MarketBeat

6 days from now

5 hours ago · IGM Biosciences (NASDAQ:IGMS - Get Free Report) last posted its earnings results on Friday, November 8th.The company reported ($1.01) earnings per share (EPS) for …

marketbeat.com

$367
OFF

Twist Bioscience: Strong Market Position And ... - Markets Insider

6 days from now

4 days ago · Twist Bioscience sees FY25 revenue $367M-$377M, consensus $373.17M Twist Bioscience reports Q4 EPS (59c), consensus (69c) Twist Bioscience sees Q1 revenue $87M, …

businessinsider.com

$367
OFF

Twist Bioscience Sees FY25 Revenue $367M-$377M ... - Markets …

6 days from now

5 days ago · Twist Bioscience reports Q4 EPS (59c), consensus (69c) Twist Bioscience sees Q1 revenue $87M, consensus $84.27M Options Volatility and Implied Earnings Moves Today, …

businessinsider.com

$367
OFF

Cautious Outlook: Unfavorable Risk/Reward Profile For Twist …

6 days from now

4 days ago · Twist Bioscience sees FY25 revenue $367M-$377M, consensus $373.17M Twist Bioscience reports Q4 EPS (59c), consensus (69c) Twist Bioscience sees Q1 revenue $87M, …

businessinsider.com

FAQs about Twist Bioscience Reports Record Revenue in 2024 - Markets Insider Coupon?

How did Twist Bioscience perform in fiscal 2024?

Twist Bioscience reported strong financial results for the first quarter of fiscal 2024. Synbio revenue grew to $26.8 million, NGS revenue jumped to $39.4 million, and Biopharma revenue was reported at $5.2 million. ...

What is the consensus EPS estimate for Twist Bioscience (Twst)?

The current consensus EPS estimate is -$0.70 on $83.75 million in revenues for the coming quarter and -$2.56 on $376.02 million in revenues for the current fiscal year. Twist Bioscience (TWST) delivered earnings and revenue surprises of 19.18% and 2.59%, respectively, for the quarter ended September 2024. ...

Is Twist Bioscience (Twst) a good stock to buy?

Twist Bioscience (NASDAQ: TWST) just reported results for the second quarter of 2024. Twist Bioscience reported earnings per share of -79 cents. This was above the analyst estimate for EPS of -81 cents. The company reported revenue of $75.30 million. This was 6.58% better than the analyst estimate for revenue of $70.65 million. ...

Why is Twist Bioscience's revenue growth important?

Twist Bioscience's revenue growth is a critical indicator of its expanding market presence and increasing demand for its synthetic DNA products. The company's improved revenue guidance suggests confidence in its continued growth trajectory, which is particularly important in the competitive Medical Diagnostics & Research industry. ...

How much did Twist Bioscience (Twst) lose?

Twist Bioscience (TWST) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.73. This compares to loss of $0.81 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 19.18%. ...

What does Twist Bioscience do?

Twist Bioscience is a synthetic biology and genomics company known for its disruptive DNA synthesis platform, which offers synthetic DNA-based products for various industries, including healthcare and agriculture. In its fiscal year 2024, Twist Bioscience reported a record revenue of $313.0 million, marking a 28% increase from the previous year. ...